OPTIMISED DOSAGE OF DIAMINOPHENOTHIAZINES IN POPULATIONS
The invention provides novel dosing regimens for Leuco-Methylthioninium (LMT) compounds which maximise the proportion of subjects in which the MT concentration will exceed concentrations in which therapeutic efficacy in relation to treatment of neurodegenerative disorders such as Alzheimer's di...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre ; ger |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | SCHELTER, Björn Olaf SHIELLS, Helen Christine WISCHIK, Claude Michel |
| description | The invention provides novel dosing regimens for Leuco-Methylthioninium (LMT) compounds which maximise the proportion of subjects in which the MT concentration will exceed concentrations in which therapeutic efficacy in relation to treatment of neurodegenerative disorders such as Alzheimer's disease and rontotemporal dementias can be achieved, while maintaining a desirable clinical profile. Also provided are LMT-containing dosage units and other compositions. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP3826639B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP3826639B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP3826639B13</originalsourceid><addsrcrecordid>eNrjZLDwDwjx9PUMdnVRcPEPdnR3VfB3U3DxdPT19PMP8HD18w_x8HSM8vRzDVbw9FMI8A8I9XEM8fT3C-ZhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfGuAcYWRmZmxpZOhsZEKAEAPi0oiA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>OPTIMISED DOSAGE OF DIAMINOPHENOTHIAZINES IN POPULATIONS</title><source>esp@cenet</source><creator>SCHELTER, Björn Olaf ; SHIELLS, Helen Christine ; WISCHIK, Claude Michel</creator><creatorcontrib>SCHELTER, Björn Olaf ; SHIELLS, Helen Christine ; WISCHIK, Claude Michel</creatorcontrib><description>The invention provides novel dosing regimens for Leuco-Methylthioninium (LMT) compounds which maximise the proportion of subjects in which the MT concentration will exceed concentrations in which therapeutic efficacy in relation to treatment of neurodegenerative disorders such as Alzheimer's disease and rontotemporal dementias can be achieved, while maintaining a desirable clinical profile. Also provided are LMT-containing dosage units and other compositions.</description><language>eng ; fre ; ger</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240821&DB=EPODOC&CC=EP&NR=3826639B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240821&DB=EPODOC&CC=EP&NR=3826639B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SCHELTER, Björn Olaf</creatorcontrib><creatorcontrib>SHIELLS, Helen Christine</creatorcontrib><creatorcontrib>WISCHIK, Claude Michel</creatorcontrib><title>OPTIMISED DOSAGE OF DIAMINOPHENOTHIAZINES IN POPULATIONS</title><description>The invention provides novel dosing regimens for Leuco-Methylthioninium (LMT) compounds which maximise the proportion of subjects in which the MT concentration will exceed concentrations in which therapeutic efficacy in relation to treatment of neurodegenerative disorders such as Alzheimer's disease and rontotemporal dementias can be achieved, while maintaining a desirable clinical profile. Also provided are LMT-containing dosage units and other compositions.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLDwDwjx9PUMdnVRcPEPdnR3VfB3U3DxdPT19PMP8HD18w_x8HSM8vRzDVbw9FMI8A8I9XEM8fT3C-ZhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfGuAcYWRmZmxpZOhsZEKAEAPi0oiA</recordid><startdate>20240821</startdate><enddate>20240821</enddate><creator>SCHELTER, Björn Olaf</creator><creator>SHIELLS, Helen Christine</creator><creator>WISCHIK, Claude Michel</creator><scope>EVB</scope></search><sort><creationdate>20240821</creationdate><title>OPTIMISED DOSAGE OF DIAMINOPHENOTHIAZINES IN POPULATIONS</title><author>SCHELTER, Björn Olaf ; SHIELLS, Helen Christine ; WISCHIK, Claude Michel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP3826639B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2024</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>SCHELTER, Björn Olaf</creatorcontrib><creatorcontrib>SHIELLS, Helen Christine</creatorcontrib><creatorcontrib>WISCHIK, Claude Michel</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SCHELTER, Björn Olaf</au><au>SHIELLS, Helen Christine</au><au>WISCHIK, Claude Michel</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>OPTIMISED DOSAGE OF DIAMINOPHENOTHIAZINES IN POPULATIONS</title><date>2024-08-21</date><risdate>2024</risdate><abstract>The invention provides novel dosing regimens for Leuco-Methylthioninium (LMT) compounds which maximise the proportion of subjects in which the MT concentration will exceed concentrations in which therapeutic efficacy in relation to treatment of neurodegenerative disorders such as Alzheimer's disease and rontotemporal dementias can be achieved, while maintaining a desirable clinical profile. Also provided are LMT-containing dosage units and other compositions.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre ; ger |
| recordid | cdi_epo_espacenet_EP3826639B1 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | OPTIMISED DOSAGE OF DIAMINOPHENOTHIAZINES IN POPULATIONS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T11%3A07%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SCHELTER,%20Bj%C3%B6rn%20Olaf&rft.date=2024-08-21&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP3826639B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |